Pherecydes Pharma SA
Pherecydes Pharma SA (ALPHE.PA) Stock Overview
Explore Pherecydes Pharma SA’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
15.8M
P/E Ratio
-2.68
EPS (TTM)
$-0.75
ROE
-0.64%
ALPHE.PA Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Pherecydes Pharma SA (ALPHE.PA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $1.17.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.68 and a market capitalization of 15.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.